Below is a partial list of our clients. SPRIG is proud to have strong on-going relationships with clients in the United States, Europe, Israel, and Asia.
- Access Closure*
- Analytics 4 Life
- Apama Medical
- Autonomic Technologies, Inc.
- Bluegrass Vascular
- Clearside Biomedical
- Corvia Medical
- Datum Dental
- EBR Systems
- Edwards Lifesciences
- Fractyl Laboratories
- Insightra Medical
- Kalila Medical*
- Laminate Medical
- Maya Medical*
- Omada Health
- OR Safety
- RAD Biomed
- RDD Pharma
- Sight Sciences
- Tryton Medical
Our client, a start-up company in Silicon Valley, CA, with a product in the atrial fibrillation market, was in need of naming their catheter and developing a product positioning statement. SPRIG worked with the client to understand the technology, customer base and key value propositions so that we could apply our customized naming protocol and present pre-screened high-quality options with select taglines. Prior to sharing name concepts, SPRIG performs a Google and USPTO preliminary search to eliminate any direct hits or potential conflicts. Within two rounds of discussions and ideation, the client was able to select a solid product name and tagline and successfully secure a trademark application.
Our client, a private company in Silicon Valley, CA, was planning its OUS launch of a novel stent system that would also prepare the market for its future product platform. SPRIG was contacted because of our proven background in stent technologies and expertise with product launches. SPRIG initiated the relationship with a senior management off-site strategy session to formalize product positioning and key messages. Within six weeks, SPRIG produced a full commercial plan, re-branded the product with new position statements and messaging, developed a product brochure and re-vamped the website. The client successfully launched the product and has leveraged the new branding at numerous tradeshows. SPRIG continues to work with the client on product awareness and tradeshow strategies in Asia, Europe and the United States.
Our client, a serial Bay Area entrepreneur who has an intellectual property portfolio, was looking to enter a new market with one of the technologies. SPRIG was approached with a request for an in-depth market analysis. Within two weeks, we performed a thorough assessment of the clinical problem, incidence rate of the clinical need, worldwide market size and opportunity, competitive landscape, and the potential for strategic partnership/acquisition. The market opportunity assessment revealed that only 25,000 annual procedures are being performed worldwide and the market opportunity would not exceed $100MM. As a result, the client decided not to move forward with this indication.
Technology Acquisition Evaluation
Our client, a multi-billion dollar company headquartered overseas, had to make a fast decision on whether to purchase a technology for a market and a geography that was new to them. Within two weeks, the SPRIG team used its extensive network to set-up and conduct in-person interviews with physician key opinion leaders to review the technology and key market entry factors. The interviews revealed an overwhelmingly positive review of the technology; however, it also identified related product portfolio issues that the company needs to address in order to make the acquisition a worthwhile investment. As a result, the company is re-addressing its entry strategy to make certain that its product map fits with the current market needs. SPRIG will continue to work with this client once their internal strategic objectives and plans are finalized.
Technology Acquisition Evaluation
Our client, a private company in Minneapolis, MN, is in the process of transitioning from a development-stage to commercial-stage company. The initial need was to upgrade their website and transition from product-centric content to company-focused initiatives. Working with the client, we rebranded the corporate logo and launched a fresh, updated, new website that provided technical product detail as well as a corporate overview, mission, and vision for future innovations. Specifically, the company was in the planning process for their pivotal trial and needed to have an updated website to use for interested and enrolling clinical sites. The client was so pleased with our work on the website they subsequently asked for our leadership on the development of product launch materials, to include product and patient brochures, animation video, and other sales tools.
Our client, a private company in Boston, MA, closed a significant round of financing and entered into an acquisition agreement with a strategic partner. SPRIG drafted the press release, sent it over the wire and conducted outreach to select industry and trade publications to build additional media interest. Because of SPRIG’s relations and targeted approach, the company received excellent coverage in the news and secured an interview with a highly renowned trade publication.
Our client, a private company in Research Triangle Park, NC, received CE Mark and is actively selling product in Europe. At the time of our initial engagement, the company was preparing for site enrollment in its U.S. Pivotal Study. The SPRIG team was asked to manage the objectives and budget for tradeshows which included plans to recruit sites for the FDA study, inservice and train European physicians on the commercially-available product, build relations with distributors, and create awareness with strategic partners. In addition to creating a strong booth presence, efforts also focused on planning off-site clinical and physician meetings, securing educational sponsorship opportunities, vetting advertisement options, and building marketing pieces, such as eblasts, mailers, ads, animations, sales sheets, to drive attendance to company-supported events. Over the past 4 years, this company has grown and hired its own marketing team, yet SPRIG continues to work on many important strategic projects for this client.
Our client, a late-stage start-up company, was preparing for a product launch of their second-generation device. Due to the competitive pricing in Europe, the company is planning on expanding their sales efforts without the aid of distributors by using more of a “tiger team” approach where a centralized team would target hospitals directly across Europe. However, since these countries are new to the sales team, they needed assistance identifying key opinion leaders and high volume centers for their target market. Using its network of physicians and researching applicable clinical trials, presentations and publications, the SPRIG team provided the client with a target list of 125 thought-leaders and high-volume operators across 15 different countries. As a result, the company is able to have a much more focused sales effort for their new product launch.
Our client, a public company in California, contacted SPRIG to serve as a project manager for the launch of a tissue valve in the Asia-Pacific region. We immediately jumped in and co-managed the cross-functional and multi-cultural launch meetings, and worked with the Asia-Pacific agency to create regionally appropriate marketing collateral. As an integral member of the team, SPRIG launched one of the first commercial tissue valves in the AP territory. As a result, the client has secured SPRIG to launch another next generation device in Europe.